Smith Ian F insider trades
Smith Ian F has filed 38 Form 4s with the SEC that we hold, for Solid Biosciences Inc. (SLDB) (Director), Foghorn Therapeutics Inc. (FHTX) (Director), Stoke Therapeutics, Inc. (STOK) (Chief Executive Officer, Director) and Odyssey Therapeutics, Inc. (ODTX) (Director). None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2022-01-05 and the latest 2026-10-06.
Solid Biosciences Inc. (SLDB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Foghorn Therapeutics Inc. (FHTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Stoke Therapeutics, Inc. (STOK)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Odyssey Therapeutics, Inc. (ODTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1197032) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms